—Vaccines Linked To Few Health Problems “” A literature review by the Institute of Medicine (IOM) concluded that very few health problems can be clearly associated with vaccines. A committee of experts found “convincing evidence” of 14 types of adverse health outcomes from eight vaccines but found no link between immunizations and serious conditions of concern, including type 1 diabetes and autism.
by David J. Hanson | September 05, 2011
—Chemical health and safety division presents 2018 awards “” The ACS Division of Chemical Health & Safety (CHAS) presented several awards during the ACS fall national meeting in Boston. The division awards recognize outstanding leadership and service in the field of chemical health and safety. The University of North Carolina, Chapel Hill’s department of chemistry and department of environment, health, and safety received the 2018 SafetyStratus College & University Health & Safety Award for an outstanding undergraduate chemical safety program. Dow Chemical received the 2018 Howard Fawcett Chemical Health & Safety Award, which recognizes outstanding contributions to the science, technology, education, and communication of chemical health and safety. Diane Grob Schmidt, a past ACS president who is a retired section head from Procter & Gamble, is the recipient of the 2018 CHAS Tillmanns-Skolnik Award for her outstanding service to the division.
by Linda Wang | October 14, 2018
—Free medications are part India’s pending new health policy “” India’s new National Health Policy, unveiled earlier this month, calls for free medicines in some situations and aims to provide quality, affordable health care to all its people. Indian Health Minister J. P. Nadda says the policy proposes free drugs, free diagnostics, and free emergency care services in all public hospitals.
by K. V. Venkatasubramanian, special to C&EN | March 27, 2017
—Drug Industry Offers Health Care Savings “” A coalition of medical industry trade groups convened at the White House last week and pledged to save Americans at least $2 trillion in health care spending over the next decade. Drugmakers, hospitals, insurance companies, and doctors hope that voluntary cuts will negate the need for government mandates if President Barack Obama succeeds in pushing universal health care legislation through Congress. "It is critical for all Americans to have access to high-quality, affordable health care coverage and services," said Billy Tauzin, president of the Pharmaceutical Research & Manufacturers of America, which represents the brand-name drug industry. The $2 trillion in savings would be achieved by reducing the projected increase in health care costs by 1.5% each year for 10 years.
by Glenn Hess | May 18, 2009
—Researchers are examining plastic’s many hazards to human health “” A panel of researchers is comprehensively analyzing the multiple hazards that plastic poses to human health throughout the material’s life cycle. The study is examining the human health effects from fossil fuel extraction for use as plastic feedstocks, everyday use and disposal of plastic, and plastic pollution, the researchers say in a paper (Ann. Global Health 2022, DOI:10.5334/aogh.3916). They are studying the health impacts of plastic additives, microplastics, and air pollution from the burning of plastics. The researchers intend to release a report on their work in March 2023. It will include science-based recommendations to prevent plastic-related disease and premature death and to incorporate the costs of such health problems into the price of plastic.
by Cheryl Hogue | September 09, 2022
—Bayer ups animal health, warns about ag “” Bayer will spend $105 million to expand animal health product manufacturing at its Kiel, Germany, location. The investment will increase output of flea and tick collars and expand production of pipettes filled with parasite-killing fluid for pet protection. The Kiel site makes 60% of Bayer’s animal health products. Separately, Bayer disclosed that poor performance in Brazil from its crop science division will hit its earnings by $350 million to $450 million this year. /articles/95/i28/Bayer-ups-animal-health-warns.html 20170710 Concentrates 95 28 /magazine/95/09528.html Bayer ups animal health, warns about ag agriculture, animal health, fleas con bus Alexander H. Tullo business Bayer ups animal health, warns about ag Chemical & Engineering News Bayer ups animal health, warns about ag Bayer ups animal health, warns about ag
by Alexander H. Tullo | July 10, 2017
—NIH-led Children’s Health Study On Hold “Health: Ambitious federal project to link environmental exposures and genetics to children’s health put on hold in light of critical expert report” An NIH-led study of children’s health, for which the agency has already spent more than $1 billion, is on hold in light of a highly critical review by a panel of the National Academies. Called the National Children’s Study (NCS), the ambitious federal project aims to link environmental exposures and genetics to the health and development of 100,000 children from before birth to age 21. But, as designed, the study lacks the scientific rationale and oversight needed to produce meaningful results, the academies panel says.
by Britt E. Erickson | June 19, 2014
—EPA Unresponsive On Children's Health “” EPA has ignored recommendations from its Children's Health Protection Advisory Committee, according to the Government Accountability Office. EPA formed the advisory committee in 1997. The committee is composed of experts in children's health from academe, health care, industry, nonprofits, and local governments. Over the past decade, it has made hundreds of suggestions to EPA regarding protection and improvement of children's health. But "EPA has largely disregarded key recommendations" from these advisers, John B. Stephenson, GAO director of natural resources and environment, told the Senate Environment & Public Works Committee on Sept. 16. For instance, when the agency proposed changes to air-quality standards for ozone, lead, and particulate matter, the advisory panel made specific recommendations related to children's health and these pollutants. "EPA did not acknowledge, was noncommittal, rejected, or offered only to consider them along with comments from the general public," Stephenson told the committee. /articles/86/i38/EPA-Unresponsive-Childrens-Health.html 20080922 Concentrates 86 38 /magazine/86/8638.html EPA Unresponsive On Children's Health con govpol environment EPA Unresponsive On Children's Health Chemical & Engineering News EPA Unresponsive On Children's Health EPA Unresponsive On Children's Health
September 22, 2008
—NIH Funds New Health Centers “” NIH's National Institute of Environmental Health Sciences will invest $6.8 million in 2008 for three new centers that will bridge the gap between basic research and clinical treatment of diseases caused by environmental factors. The Disease Investigation through Specialized Clinically Oriented Ventures in Environmental Research (DISCOVER) program fosters an integrated research approach that mixes laboratory research with population-based studies to understand how the environment interacts with biological processes to preserve health or cause disease. One of the new centers will be at Johns Hopkins University's Bloomberg School of Public Health and will focus on childhood autism in urban environments. Another, located at Columbia University School of Public Health, will focus on the effects of air pollution from traffic on children's lungs. The University of Washington will host the third new center, which will support research on the impact of traffic-related air pollution on cardiovascular diseases. /articles/86/i1/NIH-Funds-New-Health-Centers.html 20080107 Concentrates 86 1 /magazine/86/8601.html NIH Funds New Health Centers con govpol environment NIH Funds New Health Centers Chemical & Engineering News NIH Funds New Health Centers NIH Funds New Health Centers
January 07, 2008
—Pfizer To Spin Off Animal Health Unit “” Pfizer is spinning off its animal health business into a new company to be called Zoetis. The drugmaker plans an initial public offering for Zoetis, details of which will be announced in its second-quarter earnings report. The animal health unit, which makes vaccines, medicines, diagnostics, and genetic tests, had sales of roughly $4.2 billion in 2011.
by Lisa M. Jarvis | June 18, 2012